EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative Prognostic Value of Four Urinary Biomarkers for Cardiovascular and Renal Outcomes After Transcatheter Aortic Valve Implantation

Hidetoshi Yasuda, Hiroshi Iwata, Shinichiro Doi, Takuma Koike, Soshi Moriya, Yuichi Chikata, Takehiro Funamizu, Norihito Takahashi, Ryota Nishio, Seiji Koga, Hirohisa Endo, Iwao Okai und 2 weitere

Cardiorenal Medicine · 2026

DOI: 10.1159/000550414 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cardiorenal Medicine, 2026. Verfasst von Hidetoshi Yasuda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Biomarkers, Transcatheter Aortic Valve Replacement, Alpha-Globulins, Fatty Acid-Binding Proteins. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Renal risk stratification after transcatheter aortic valve implantation (TAVI) remains anchored to filtration metrics such as serum creatinine and estimated glomerular filtration rate (eGFR). These indices may not capture early tubular injury, which is clinically relevant in older TAVI populations. We therefore investigated whether four urinary biomarkers—N-acetyl-β-D-glucosaminidase (NAG), liver-type fatty acid–binding protein (L-FABP), β2-microglobulin, and α1-microglobulin—measured the day after TAVI, are associated with subsequent cardio-renal outcomes.

Methods

We enrolled 191 consecutive patients undergoing TAVI in a single-center cohort within the LAPLACE-TAVI registry (February 2016–December 2019). Spot urine collected 12–18 hours post-procedure was assayed for four urinary markers. The primary endpoint was a 24-month composite of all-cause death or first heart-failure hospitalization; a renal composite used contemporary surrogate criteria. Multivariable Cox models adjusted for clinical covariates including eGFR. Biomarkers were examined using cohort medians as prespecified cut points.

Results

Median follow-up was 1.8 years (interquartile range [IQR] 1.1–2.0); the primary endpoint occurred in 27/191 (14.1%). NAG showed no correlation with eGFR (r = −0.03, p = 0.68), whereas β2-microglobulin and α1-microglobulin correlated inversely with eGFR (r = −0.27, p = 0.002; r = −0.34, p < 0.001); L-FABP was not correlated (r = −0.09, p = 0.21). Patients above the cohort median for NAG (6.8 IU/L) experienced higher 2-year event rates, with early separation of Kaplan–Meier curves (log-rank p = 0.02). In adjusted models, both high NAG (hazard ratio [HR] 2.63, 95% confidence interval (CI) 1.17–6.46; p = 0.02) and high L-FABP (HR 2.48, 95% CI 1.08–6.16; p = 0.03) remained independently associated with the primary endpoint, whereas β2-microglobulin and α1-microglobulin were not. Creatinine and eGFR were comparable across NAG strata; renal composite events were higher in the high-NAG group but did not reach statistical significance.

Conclusion

A single urinary NAG and L-FABP measurement within 24 hours post TAVI identified increased 2-year risk of death or heart-failure hospitalization despite preserved filtration indices. Although limited by sample size and single-center design, these pilot data support external validation and the evaluation of biomarker-guided surveillance and reno-protective strategies following TAVI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersTranscatheter Aortic Valve ReplacementAlpha-GlobulinsFatty Acid-Binding ProteinsAortic Valve Stenosisbeta 2-MicroglobulinHumansFemaleMalePrognosisGlomerular Filtration RateAcetylglucosaminidaseAged, 80 and overAgedRisk Assessment

Stichwörter der Autor:innen

Cardiovascular and renal outcomesN-acetyl-β-d-glycosaminidaseTranscatheter aortic valve implantationUrinary biomarkers

Substanzen

BiomarkersAlpha-Globulinsalpha-1-microglobulinFatty Acid-Binding ProteinsAcetylglucosaminidasebeta 2-Microglobulin

Autor:innen und Institutionen

  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan, hiroiwata-circ@umin.ac.jp.

Zitieren

APA

Yasuda, H., Iwata, H., Doi, S., Koike, T., Moriya, S., Chikata, Y., Funamizu, T., Takahashi, N., Nishio, R., Koga, S., Endo, H., Okai, I., Okazaki, S., & Minamino, T. (2026). Comparative Prognostic Value of Four Urinary Biomarkers for Cardiovascular and Renal Outcomes After Transcatheter Aortic Valve Implantation. Cardiorenal Medicine. https://doi.org/10.1159/000550414

Vancouver

Yasuda H, Iwata H, Doi S, Koike T, Moriya S, Chikata Y, et al. Comparative Prognostic Value of Four Urinary Biomarkers for Cardiovascular and Renal Outcomes After Transcatheter Aortic Valve Implantation. Cardiorenal Medicine. 2026. doi:10.1159/000550414

BibTeX
@article{Yasuda2026,
  author = {Yasuda, Hidetoshi and Iwata, Hiroshi and Doi, Shinichiro and Koike, Takuma and Moriya, Soshi and Chikata, Yuichi and Funamizu, Takehiro and Takahashi, Norihito and Nishio, Ryota and Koga, Seiji and Endo, Hirohisa and Okai, Iwao and Okazaki, Shinya and Minamino, Tohru},
  title = {Comparative Prognostic Value of Four Urinary Biomarkers for Cardiovascular and Renal Outcomes After Transcatheter Aortic Valve Implantation},
  journal = {Cardiorenal Medicine},
  year = {2026},
  doi = {10.1159/000550414}
}
Kostenlos starten →